While we wait .... Probably mentioned this before, but I

New Post Public Reply Private Reply Replies (2) Message Board
TechGuru
792
While we wait ....

Probably mentioned this before, but I am very interested in the memory application of VX. My wife does not take it lightly when I explain that I called her by a different name because of my memory causing me few “near misses” to the ICU .

Posted some remarks about this some time back, however Dr. Patterson (via twitter) and somebody else in this board (sorry, forgot who posted it) highlighted this article: “The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory” .

https://www.researchgate.net/publication/2833...and_memory

This relates to us because CCL3 binds to our receptor CCR5, so our antagonist will have direct effect in this findings which indeed is what the researchers conclude (they even used Maraviroc):

Quote:
Importantly, our in vivo data demonstrate that detrimental effects of CCL3 upon synaptic transmission and plasticity were also observed in hippocampal slices from animals sub-chronically injected with CCL3 in ventricles. The detrimental effect of CCL3 appears mediated by CCR5 receptor, as it was reversed by the specific antagonist Maraviroc. CCR5 is one of the cognate CCL3 receptor previously reported to be expressed by astrocytes, microglia and neurons. Our data extend the known neuromodulatory role of the CCR5 receptor. Indeed, CCR5 was found to enhance pain perception at inflammatory sites and to modulate glutamate release in human neocortex

And:
Quote:
In line with the latter studies, blockade of CCR5 by Maraviroc impacts plasticity and memory only in the presence of CCL3 without any effect by itself, finally suggesting that the tonic CCR5 activity is not necessary to memory formation in non-pathological conditions. Altogether, our data highlight for the first time that abnormal activation of the CCR5 pathway is prone to impair synaptic processes leading to memory loss, supporting a role in pathologies associated with CCL3 upsurge.


Another proof (as if we needed more) is that a high percentage of individuals with true photographic memory, Hyperthymesia (or photographic memory) are homozygous for the deletion variant of the ccr5 gene.

I attach below for completeness cut-and-paste from my former post in regards to this matter. Once VX is available I might try to get some to improve my memory & avoid risking my life with my wife.

There have been some reports of CCR5 being associated with much improved memory (Hyperthymesia), and reports of the CRISP-edited Chinese girls that where given the gene mutation was really to improve their performance.
https://biohackinfo.com/news-crispr-babies-cc...-immunity/

Some scientific experiments with rats indeed have indeed demonstrated that CCR5 is a suppressor for cortical plasticity and hippocampal learning and memory. This was discovered on a reverse genetic memory screen. Basically, some mice with heterozygous deletion of CCR5 performed much better than other mice.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5213777/

Their conclusion: CCR5 overexpression leads to learning and memory deficits (we are talking mice here).

However, there exist HAND or HIV-associated neurocognitive disorders which remain a chronic issue, with significant effects on patients ability to perform activities of daily living, quality of life, employment, medication adherence, and survival.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365228/

CCR5 chemokine receptor neurotropism has been identified as a biomarker of this CNS (central nervous system) disorder.
Quote:
CCR5 chemokine receptor neurotropism Viral envelope glycoproteins can fuse with only those cells expressing both CD4 and an HIV co-receptor, of which CCR5 has been identified as the most important for microglia and CNS macrophages. CCR5 receptors are upregulated on activated CD4+ and CD8+ T cells, enhancing antigen-presenting cell interaction, T cell trafficking into tissues, and cytokine production. In response to infection or inflammation, monocytes, microglia, astrocytes, and neurons express CCR5 ligands, which increase the migration of CCR5+ T cells into the CNS. Locally, these effector T cells secrete CCR5 ligands, which amplify the immune response. A subset of CCR5-tropic viruses have been found to be highly fusogenic, requiring lower expression levels of CCR5 and CD4 to infect cells, leading to greater apoptosis. There is now good evidence that the vast majority of HIV strains in the brain are CCR5 tropic. Given the intrinsic role of CCR5 in CNS disease, it is suggested that CCR5 antagonists, such as maraviroc, may be able to reduce the migration and then activation of effector CD8+ T cells in the CNS and hence reduce the neurocognitive sequelae of HIV. This is now being assessed


Quote:
A recent prospective, open-label pilot randomized controlled trial in individuals with viral suppression and stable ART for 12 months found maraviroc-intensified HAART improved global neurocognitive performance at both 6 and 12 months without significant side effects


So, it seems that VX (Leronlimab) WILL help with HAND and improves cognition and memory !!!

Perhaps OHM would add to his list two more indications for Vyrologix:

1) Stupidity
2) Bad memory

I am suffering of a mild case of one and critical of the other.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 4

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 4

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 11

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 5

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 3

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 6

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 7

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 5

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading

Top 5 Most Recently Viewed Articles

Promising Results from CRISPR Therapeutics in Blood Cancer Trials

Updated Category News Views 126

Updates from CRISPR Therapeutics AG on Breakthrough Therapies CRISPR Therapeutics AG (NASDAQ: CRSP) has recently shared impressive updates regarding zugocaptagene geleucel (zugo-cel), a promising investigational CAR T therapy designed to target CD19. This therapy is currently under development for various hematologic malignancies and autoimmune diseases. As new clinical...

Continue Reading
Analyzing Recent Trends in GATX's Short Interest Dynamics

Updated Category News Views 123

Understanding GATX's Short Interest Trends GATX Corporation (NYSE: GATX) has witnessed a notable increase in its short interest, which has risen by 15.74% since the last reporting period. This increase indicates that there are currently around 1.25 million shares sold short, representing 6.03% of all available shares for trading. Given the company's average trading...

Continue Reading
InterDigital's Innovations in Immersive Sports Technology

Updated Category News Views 160

InterDigital to Showcase Game-Changing Technologies InterDigital, Inc. (NASDAQ: IDCC), known for its cutting-edge mobile, video, and AI technology innovations, is set to reveal exciting developments in immersive media technologies at an upcoming major conference. Bill Redmann, the Director of Standards for Immersive Media Technologies, will play a pivotal role during the...

Continue Reading
Deadline for SelectQuote Investors Approaching Soon

Updated Category News Views 167

Investors Urged to Take Action on SelectQuote Losses Attention investors! If you have experienced financial losses in SelectQuote, now is the time to act. Faruqi & Faruqi, LLP is leading the charge in investigating claims on behalf of investors who may have suffered due to the company's recent developments. Investors are proudly encouraged to reach out if they believe...

Continue Reading
Understanding Recent Options Activities for Constellation Energy

Updated Category News Views 183

The Buzz Around Constellation Energy's Options Recently, there has been a noticeable increase in bullish behavior towards Constellation Energy, particularly observed through their options trading strategies. Our thorough assessment of the options trade history for Constellation Energy Corp (NASDAQ: CEG) has unveiled a remarkable trend: an impressive 55 unusual trades were...

Continue Reading